Amy Luchsinger
Nurse Practitioner · East Syracuse, NYNPI 1285067637
Payments from drug & device makers
Across 201 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$503
- Amgen$342
- Novo Nordisk$249
- Amarin Pharma, Inc.$178
- GSK$172
- AstraZeneca$145
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,068100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $503 |
| Amgen | 29 | $342 |
| Novo Nordisk | 16 | $249 |
| Amarin Pharma, Inc. | 13 | $178 |
| GSK | 11 | $172 |
| AstraZeneca | 8 | $145 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $121 |
| Almatica Pharma LLC | 7 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $109 |
| Bayer | 5 | $97 |
| Pfizer | 6 | $96 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $87 |
| Astellas Pharma US Inc | 4 | $79 |
| Lilly USA, LLC | 5 | $78 |
| Merck | 4 | $76 |
| Boehringer Ingelheim | 5 | $74 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Corcept Therapeutics | 3 | $58 |
| Johnson & Johnson | 1 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| UCB, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Shield Therapeutics Inc | 2 | $37 |
| Boston Scientific | 1 | $35 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Abbott | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $15 |
| Corium, LLC | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$3,068 in reported general payments places this provider in the 90th percentile of 4,112 nurse practitioner providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $28,918 |
| OzempicSemaglutide | 15 | $16,818 |
| PaxlovidNirmatrelvir/Ritonavir | 25 | $6,643 |
| Betamethasone Dipropionate | 19 | $846 |
| Cephalexin | 34 | $841 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $812 |
| Potassium Chloride | 12 | $693 |
| Doxycycline Hyclate | 87 | $688 |
| Bupropion XlBupropion Hcl | 15 | $567 |
| Rosuvastatin Calcium | 25 | $532 |
| Atorvastatin Calcium | 53 | $469 |
| Ezetimibe | 14 | $464 |
| Valsartan | 13 | $453 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 66 | $436 |
| Levothyroxine Sodium | 47 | $363 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $74 | $28,91818 claims |
| Novo NordiskOzempic | $249 | $16,81815 claims |
| PfizerPaxlovid | $96 | $6,64325 claims |
| Almatica Pharma LLCSertraline Hcl | $119 | $24716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in East Syracuse
- Kerry AhernEast Syracuse$55K
- Alicia RayderEast Syracuse$13K
- Jennifer PichoskeEast Syracuse$12K
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.